# SITC Immunotherapy Guidelines > Mobile access to clinical practice guidelines for cancer immunotherapy. (iPhone/iPad app by SOCIETY FOR IMMUNOTHERAPY OF CANCER, INC..) - Source: https://appshunter.io/ios/app/sitc-immunotherapy-guidelines/id1555408470 (this page in markdown: same URL + `.md`) - Developer: [SOCIETY FOR IMMUNOTHERAPY OF CANCER, INC.](https://appshunter.io/developer/1414524791) - Category: Medical, Health & Fitness - Price: Free - Rating: 4.81/5 from 77 App Store ratings · 1 written reviews indexed - Age rating: 17+ - Requires: iOS 12.0 · 158 MB - Languages: English, German - Released: 2021-08-30 - Data updated: 2026-06-10 - Monetization: free - User reviews in markdown: https://appshunter.io/ios/app/sitc-immunotherapy-guidelines/id1555408470/reviews.md ## What is SITC Immunotherapy Guidelines? The Society for Immunotherapy of Cancer (SITC) Clinical Practice Guidelines (CPG) Mobile App is the first and only tool of its kind, offering direct, easy, portable access to SITC’s CPGs via phone or tablet. Highlighting key information from SITC’s published guidelines, the SITC CPG App features evidence- and expert consensus based-recommendations on all aspects of immunotherapy treatment as well as interactive tools and companion educational resources. From biomarkers and therapy selection to quality of life and management of immune-related adverse events, busy clinicians will find the SITC CPG App as the go-to resource on when and how to use immunotherapy to help improve outcomes for patients with cancer. Key App Features *Clean and simple navigation with a modern interface *Interactive tools and tables at your fingertips *Advanced search functionality for fast access to the content clinicians need *Bookmarking and annotation capabilities throughout for future fast-reference *Timely updates when new practice-changing data or approvals become available *Companion educational offerings to enhance understanding of guideline recommendations *Free download with open-access content About SITC’s Guidelines SITC’s Clinical Practice Guidelines (CPGs) offer a vital resource for the practicing oncology community by providing practical, actionable recommendations to help cancer care providers develop immunotherapy treatment plans for their patients. The CPGs are developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations on when and how to use immunotherapy to help improve outcomes for patients with cancer. SITC uses as a model the Institute of Medicine's 2011 "Standards for Developing Trustworthy Clinical Practice Guidelines" to ensure a fair, transparent and balanced process for creating the CPGs. Each CPG expert panel is comprised of a comprehensive mix of academic physicians and researchers, nurses, patients, and patient advocates invited from institutions across the United States. The guidelines are reviewed on an ongoing basis to account for newly available clinical trial data and FDA approvals. About SITC SITC is a 501(c)(3) not-for-profit medical professional society of influential research scientists, physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders dedicated to improving cancer patient outcomes by advancing both the science behind – and the clinical application of – cancer immunotherapy. SITC aims to one day make the word “cure” a reality for cancer patients everywhere. www.sitcancer.org
 sitcancer.org/CPG-app On social - #SITCGuidelines ## Key features - Portable access to clinical practice guidelines - Interactive tools and tables - Advanced search functionality - Bookmarking and annotation - Timely updates on new data - Companion educational resources ## Recent user reviews (1 of 1) All indexed reviews: https://appshunter.io/ios/app/sitc-immunotherapy-guidelines/id1555408470/reviews.md ### 5/5 — Nice app *2022-01-06* Nice information!!! ## Frequently asked questions about SITC Immunotherapy Guidelines ### What is SITC Immunotherapy Guidelines? SITC Immunotherapy Guidelines is a mobile application that provides direct, portable access to the Society for Immunotherapy of Cancer's Clinical Practice Guidelines (CPGs). It offers evidence- and expert consensus-based recommendations on all aspects of immunotherapy treatment for cancer patients. ### What kind of information is available in SITC Immunotherapy Guidelines? The app covers key information on immunotherapy treatment, including biomarkers, therapy selection, quality of life, and management of immune-related adverse events. It features interactive tools, tables, and companion educational resources to enhance understanding. ### Is SITC Immunotherapy Guidelines free to download? Yes, SITC Immunotherapy Guidelines is free to download and offers open-access content. There are no in-app purchases or subscription fees required to access the guidelines. ### How often is SITC Immunotherapy Guidelines updated? The app receives timely updates when new practice-changing data or approvals become available. The guidelines are reviewed on an ongoing basis to account for newly available clinical trial data and FDA approvals, with the last update on March 19, 2024. ### What devices support SITC Immunotherapy Guidelines? SITC Immunotherapy Guidelines is available for iPhone, iPad, and iPod devices. It is designed for portability and easy access on the go. ### What is the age rating for SITC Immunotherapy Guidelines? The app has an age rating of 17+, indicating it is intended for mature audiences. This is likely due to the complex medical information and professional context of the guidelines. ### Does SITC Immunotherapy Guidelines have ads? No, SITC Immunotherapy Guidelines does not contain advertisements. The app is ad-free, allowing for an uninterrupted user experience focused on medical information. ### How does SITC Immunotherapy Guidelines help clinicians? The app serves as a go-to resource for busy clinicians, offering fast access to essential information on when and how to use immunotherapy. Features like advanced search, bookmarking, and annotation facilitate quick reference and informed decision-making. ## Version history (last 5 releases) ### 1.7 — 2024-03-19 - Guideline content updates. - Reflects applicable new FDA approvals and practice changing data. - Also includes technical update with minor bug fixes. ### 1.5 — 2023-10-06 - Technical update with minor bug fixes - New guidelines, tools, and resources added ### 1.4 — 2023-03-20 SITC continuously evaluates the field for emerging data and new FDA approvals. This new app version includes updated content for existing guidelines, new interactive tools and updated treatment algorithms, and minor bug fixes and performance improvements. ### 1.3 — 2022-11-01 SITC continuously evaluates the field for emerging data and new FDA approvals. This new app version includes additional guidelines, updated content for existing guidelines, new interactive tools and treatment algorithms, technical improvements to user accounts, and minor bug fixes and performance improvements. ### 1.2 — 2022-06-03 - Technical update - Minor bug fixes ## More apps by SOCIETY FOR IMMUNOTHERAPY OF CANCER, INC. - [SITC 2024](https://appshunter.io/ios/app/sitc-2024/id6670398862) - [SITC 2025](https://appshunter.io/ios/app/sitc-2025/id6753675214) All apps by SOCIETY FOR IMMUNOTHERAPY OF CANCER, INC.: https://appshunter.io/developer/1414524791 --- *Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-10.*